LYTENAVA™ is the first and only approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the European Union (EU) and United Kingdom (UK)2.8 million injections of repackaged ...

LYTENAVATM is the first and only approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the European Un ...

Outlook Therapeutics commenced commercial launch of LYTENAVA™ (bevacizumab gamma) in Germany and the UK as a treatment for wet AMD. In the United States, ONS-5010/LYTENAVA™ is ...

BMO Financial Group made changes to its senior executive ranks including the appointment of Aron Levine as group head and ...

A CRN analysis found that Nvidia finished the first quarter with more than double the revenue of what Intel and AMD earned ...

These include, among others, the success of Outlook Therapeutics' commercial launch of LYTENAVA™ in Germany ... the therapeutic potential of LYTENAVA™ as a treatment of wet AMD, expectations ...

In a landmark event that reaffirms its commitment to advancing Sri Lanka’s digital landscape, Lenovo, the global technology ...

In 2024, Nvidia’s revenue soared to $130.5 billion, with AI-driven data center sales accounting for nearly 80% of its growth, ...

Detailed price information for Palantir Technologies Inc Cl A (PLTR-Q) from The Globe and Mail including charting and trades.

Matrox Video Unreal Engine plug-in lets OEMs & system integrators develop high-res, broadcast-grade virtual production & ...

Back in 2022, billionaire Stanley Druckenmiller made a sizable bet on chipmaker Nvidia. The company has gone on to become one ...